Login / Signup

Intestinal disposition of quercetin and its phase-II metabolites after oral administration in healthy volunteers.

Clément ChaletJari RubbensJan TackGuus S DuchateauPatrick Augustijns
Published in: The Journal of pharmacy and pharmacology (2018)
This study highlights the intestinal metabolism and excretion of quercetin and its conjugates in humans and gives insights into the relevant concentrations which should be used to investigate potential food-drug interactions in vitro.
Keyphrases
  • phase ii
  • clinical trial
  • open label
  • human health
  • ms ms
  • phase iii
  • randomized controlled trial
  • risk assessment
  • cancer therapy
  • placebo controlled
  • climate change
  • study protocol